Home/Filings/4/0000905148-24-000774
4//SEC Filing

BRUNK GERALD A 4

Accession 0000905148-24-000774

CIK 0001980845other

Filed

Feb 20, 7:00 PM ET

Accepted

Feb 21, 4:20 PM ET

Size

11.8 KB

Accession

0000905148-24-000774

Insider Transaction Report

Form 4
Period: 2024-02-20
Transactions
  • Award

    Common Shares

    2024-02-20$10.00/sh+644,965$6,449,650993,651 total(indirect: See Notes)
  • Award

    Common Shares

    2024-02-20$10.00/sh+155,035$1,550,350238,851 total(indirect: See Notes)
Holdings
  • Common Shares

    (indirect: See Notes)
    1,341,790
  • Common Shares

    (indirect: See Notes)
    44,647
  • Common Shares

    (indirect: See Notes)
    1,077,386
  • Common Shares

    (indirect: See Notes)
    152,974
Footnotes (8)
  • [F1]These securities are held by Lumira Ventures IV, L.P. ("Lumira IV").
  • [F2]These securities are held by Lumira Ventures IV (International), L.P. ("Lumira IV Int'l").
  • [F3]These securities are held by Lumira Ventures III, L.P. ("Lumira III").
  • [F4]These securities are held by Lumira Ventures III (International), L.P. ("Lumira III Int'l").
  • [F5]These securities are held by Merck Lumira Biosciences Fund, L.P. ("Merck-Lumira").
  • [F6]These securities are held by Merck Lumira Biosciences Fund (Quebec), L.P. ("Merck-Lumira B" and, together with Lumira III, Lumira III Int'l, Lumira IV, Lumira IV Int'l, and Merck-Lumira, the "Lumira Entities").
  • [F7]Mr. Brunk is an executive officer of certain entities controlling and/or managing the Lumira Entities. Mr. Brunk disclaims beneficial ownership of the Common Shares held by the Lumira Entities, except to the extent of his pecuniary interest therein, if any. Lumira III and Lumira III Int'l are controlled by their general partner, Lumira Ventures III GP, L.P., and managed by Lumira Capital Investment Management Inc. ("Lumira Mgmt"). Lumira Ventures III GP, L.P. is controlled by its general partners, Lumira III GP Inc. and Lumira III GP Holdings Co. Lumira IV and Lumira IV Int'l are controlled by their general partner, Lumira IV GP 2020 Inc., and managed by Lumira Mgmt. Merck-Lumira and Merck-Lumira B are controlled by their general partner, Lumira Capital GP, L.P., and managed by Lumira Mgmt. (Continued in following footnote).
  • [F8](Continued from prior footnote). Lumira Capital GP, L.P. is controlled by its general partners, Lumira GP Inc. and Lumira GP Holdings Co. Mr. Brunk is an executive officer of each of Lumira III GP Inc., Lumira III GP Holdings Co., Lumira IV GP 2020 Inc., Lumira GP Inc., Lumira GP Holdings Co. and Lumira Mgmt. Each of Lumira III GP Inc., Lumira III GP Holdings Co., Lumira IV GP 2020 Inc., Lumira GP Inc., Lumira GP Holdings Co., Lumira Mgmt and Mr. Brunk may be deemed to beneficially own the securities held by the respective Lumira Entities, but each disclaims beneficial ownership except to the extent of their respective pecuniary interests therein, if any.

Documents

1 file

Issuer

enGene Holdings Inc.

CIK 0001980845

Entity typeother

Related Parties

1
  • filerCIK 0001380226

Filing Metadata

Form type
4
Filed
Feb 20, 7:00 PM ET
Accepted
Feb 21, 4:20 PM ET
Size
11.8 KB